Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Prospective Study to Assess the Safety and Effectiveness Profile of Beltavac® Polymerized With Alternaria Alternata

NCT03604718 is registered in ClinicalTrials.gov with Probelte Pharma S.L.U. as lead sponsor.

NCT NCT03604718
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03604718 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Prospective Study to Assess the Safety and Effectiveness Profile of Beltavac® Polymerized With Alternaria Alternata
Lead sponsor
Probelte Pharma S.L.U.
Phase
Observational
Overall status
Completed
Start date
June 7, 2018
Completion date
January 20, 2023
Enrollment
65 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

rhinoconjunctivitis with or without allergic asthma